21st Annual Winter Seminar: Essential Psychopharmacology is organized by Harvard Medical School (HMS) and will be held during Feb 19 - 23, 2018 Naples Beach Hotel and Golf Club, Naples, Florida, United States of America.
The target audience for this medical event is psychiatry, psychology, medicine, surgery, nursing, social work, and counseling. This CME Conference has been approved for a maximum of 15.00 AMA PRA Category 1 Credits.
Course Description :
This course will provide a simplified and clinically relevant updated review of neurobiology and brain function. Areas of emphasis will be the psychopharmacologic of treatment of schizophrenia, bipolar disorder, depression, anxiety, substance abuse, addictions, sleep disorders and borderline personality. The effectiveness of atypical and conventional anti-psychotic drugs as well as long acting new medications will be reviewed. The course will address: strategies for bipolar patients who are noncompliant or treatment resistant; use of ketamine with risks and benefits for treatment resistant depression; approaches to the acutely psychotic, recovering psychotic patient, and the concept of early intervention. Educational presentation will be in seminar format and include lectures, participant discussion and Q&A.
Learning Objectives :
Upon completion of this activity, participants will be able to:
• Evaluate psychotropic drug treatment options with particular emphasis on recent advances and practical prescribing information;
• Analyze the latest research in neurobiology and brain function;
• Implement treatment strategies for depressive and bipolar patients, including bipolar patients who are noncompliant or treatment resistant;
• Determine the use of ketamine with its benefits and hazards in treatment resistant depression;
• Incorporate evidence-based approaches to treating acutely psychotic and recovering psychotic patients;
• Determine when to implement medical switch versus augmentation strategies for treatment-resistant depression;
• Analyze the role of benzodiazepines in the treatment of generalized anxiety disorder, obsessive symptoms, panic symptoms, traumatic syndromes;
• Evaluate psychopharmacologic treatment of sleep disorders;
• Identify the mechanisms and treatment for alcohol and substance abuse disorders;
• Determine the role of antidepressants in the life cycle of women;
• Describe the use of stimulants in adult individuals with psychiatric disorders;
• Identify mechanisms of sleep disorders and their effective psychopharmacologic treatment;
• Review latest findings about inflammation and stress as they apply to the treatment of depression and anxiety spectrum disorders;
• Update the clinical approach to problems in geriatric psychopharmacology with emphasis on newly emerging medication treatment.
|Registration Type||End Date||Price|
|Physicians and Allied Health Professionals - Early Fee||15 Dec,2017||USD 975.00|
|Physicians and Allied Health Professionals - Regular Fee||18 Feb,2018||USD 1075.00|
|Residents and Fellows in Training and Full-time Students - Early Fee||15 Dec,2017||USD 695.00|
|Residents and Fellows in Training and Full-time Students - Regular Fee||18 Feb,2018||USD 695.00|